Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Harbor–UCLA Medical Center · UCLA Medical Center
Indexed incrossrefpubmed
Abstract
Objective
To explore the safety and efficacy of psilocybin in patients with advanced-stage cancer and reactive anxiety.
Design
A double-blind, placebo-controlled study of patients with advanced-stage cancer and anxiety, with subjects acting as their own control, using a moderate dose (0.2 mg/kg) of psilocybin.
Citation impact
1,208
total citations
- FWCI
- 20.02
- Percentile
- 100%
- References
- 30
Citations per year
Authors
7Topics & keywords
Topics
Keywords
- Psilocybin
- Anxiety
- Mood
- Psychology
- Psychiatry
- Profile of mood states
- Clinical psychology
- Beck Depression Inventory
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.